https://pharmatlas.org/ 2026-04-06T09:02:30+00:00 https://pharmatlas.org/ https://pharmatlas.org/lib/exe/fetch.php?media=logo.png text/html 2026-02-13T01:29:51+00:00 Anonymous (anonymous@undisclosed.example.com) https://pharmatlas.org/doku.php?id=cardio:hf:eplerenone&rev=1770946191&do=diff Eplerenone Eplerenone is a selective Mineralocorticoid Receptor Antagonist (MRA). It blocks aldosterone at the collecting duct and reduces cardiac remodeling. Used in: * Heart Failure with Reduced EF * Post–myocardial infarction with LV dysfunction * Resistant Hypertension ---------- Mechanism of Action Eplerenone selectively antagonizes the mineralocorticoid (aldosterone) receptor. text/html 2026-02-13T01:26:49+00:00 Anonymous (anonymous@undisclosed.example.com) https://pharmatlas.org/doku.php?id=cardio:hf:spironolactone&rev=1770946009&do=diff Spironolactone Spironolactone is a Potassium-Sparing Diuretic and a Mineralocorticoid Receptor Antagonist (MRA). It blocks the effects of aldosterone at the collecting duct. Used in: * Heart Failure with Reduced EF * Resistant Hypertension * Cirrhosis with ascites * Primary hyperaldosteronism ----------